Resistance of pleural mesothelioma cell lines to apoptosis: relation to expression of Bcl-2 and Bax
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
A failure of normal apoptosis, often due to mutant p53, may contribute to the formation of a cancer and to its resistance to therapy. Mesothelioma, an asbestos-induced tumor, is highly resistant to therapy but generally expresses wild-type p53. We asked whether mesothelioma was resistant to apoptosis and whether resistance was associated with altered expression of the antiapoptotic protein Bcl-2 or proapoptotic protein Bax. We found that three mesothelioma cell lines (1 with wild-type p53) were highly resistant to apoptosis induced by oxidant stimuli (asbestos, H 2 O 2) or nonoxidant stimuli (calcium ionophore) compared with primary cultured mesothelial cells. By immunostaining, one of these three lines expressed Bcl-2 but only during mitosis. By immunoblotting, 3 of 14 additional mesothelioma lines (9 of 14 with wild type p53) expressed Bcl-2 but all 14 of 14 expressed the proapoptotic Bax, giving a low ratio of Bcl-2 to Bax. We conclude that mesothelioma cell lines are resistant to apoptosis and that the failure in apoptosis is not explained by Bcl-2 but by other mechanisms that counteract the proapoptotic effect of Bax.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boylan, A. M., Sanan, D. A., Sheppard, D., & Broaddus, V. C. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118246 · Cited by 86
Self-citation
Research works printed but not linked: 44
- 10.1002/(SICI)1097-0215(19960422)69:2<114::AID-IJC8>3.0.CO;2-3 · doi:10.1002/(sici)1097-0215(19960422)69:2<114::aid-ijc8>3.0.co;2-3
- 10.1165/ajrcmb.15.1.8679218 · DOI · Paper page
- 10.1016/0092-8674(93)90508-N · DOI · Paper page
- 10.1007/BF00685817 · doi:10.1007/bf00685817
- Brambilla E., 1996, Am. J. Pathol., 149, 1941
- 10.1165/ajrcmb.17.6.f141 · DOI
- 10.1172/JCI119010 · DOI · Paper page
- 10.1002/(SICI)1096-9896(199704)181:4<362::AID-PATH764>3.0.CO;2-Y · doi:10.1002/(sici)1096-9896(199704)181:4<362::aid-path764>3.0.co;2-y
- 10.1038/374733a0 · DOI · Paper page
- Chresta C. M., 1996, Cancer Res., 56, 1834
- 10.1046/j.1365-2141.1997.382680.x · DOI
- 10.1006/bbrc.1994.1531 · DOI
- 10.1083/jcb.127.6.1729 · doi:10.1083/jcb.127.6.1729
- 10.1093/carcin/13.8.1359 · DOI
- 10.1002/(SICI)1097-0215(19960422)69:2<100::AID-IJC5>3.0.CO;2-4 · doi:10.1002/(sici)1097-0215(19960422)69:2<100::aid-ijc5>3.0.co;2-4
- 10.1101/gad.10.4.461 · DOI · Paper page
- Herod J. J. O., 1996, Cancer Res., 56, 2178
- 10.1006/bbrc.1996.1750 · doi:10.1006/bbrc.1996.1750
- Jiang S. X., 1996, Am. J. Pathol., 148, 837
- Kuypers F. A., 1996, Blood, 87, 1179, 10.1182/blood.V87.3.1179.bloodjournal8731179 · DOI · Paper page
- 10.1016/0092-8674(93)90719-7 · DOI · Paper page
- Lu Q.-L., 1994, J. Cell Sci., 107, 363, 10.1242/jcs.107.2.363 · DOI
- McDonnell T. J., 1992, Cancer Res., 52, 6940
- Meijerink J. P. P., 1995, Leukemia, 9, 1828
- Metcalf R. A., 1992, Cancer Res., 52, 2610
- Miyashita T., 1994, Oncogene, 9, 1799
- 10.1165/ajrcmb.16.1.8998073 · DOI
- 10.3109/07357909609018904 · DOI · Paper page
- Naumovski L., 1994, Blood, 83, 2261, 10.1182/blood.V83.8.2261.2261 · DOI
- 10.1016/0092-8674(94)90188-0 · DOI · Paper page
- 10.1016/0092-8674(93)90509-O · DOI · Paper page
- 10.1200/JCO.1996.14.3.1007 · DOI
- 10.1126/science.275.5302.967 · DOI · Paper page
- 10.1083/jcb.124.1.1 · DOI · Paper page
- Reynolds J. E., 1994, Cancer Res., 54, 6348
- 10.1073/pnas.92.17.7834 · DOI · Paper page
- 10.1007/BF00195777 · doi:10.1007/bf00195777
- 10.1200/JCO.1996.14.5.1604 · DOI
- 10.1126/science.7878463 · DOI · Paper page
- 10.1126/science.7878464 · DOI · Paper page
- 10.1016/0092-8674(91)90002-G · DOI · Paper page
- 10.1177/42.4.7907352 · DOI
- 10.1016/0092-8674(95)90411-5 · DOI · Paper page
- 10.1038/369321a0 · DOI · Paper page
Cited by
The molecular basis of asbestos induced lung injury
Kamp, D. W., & Weitzman, S. A. (1999) · Thorax · doi:10.1136/thx.54.7.638 · Cited by 345
Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases
Shukla, A., Gulumian, M., Hei, T. K., Kamp, D., Rahman, Q., & Mossman, B. T. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00060-1 · Cited by 288
Role of Mutagenicity in Asbestos Fiber-Induced Carcinogenicity and Other Diseases
Huang, S. X. L., Jaurand, M.-C., Kamp, D. W., Whysner, J., & Hei, T. K. (2011) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2011.556051 · Cited by 163
“…et al., 1997; Dopp et al., 1995a; Goldberg et al., 1997; Hamilton et al., 1996; Jimenez et al., 1997; Kido et al., 2008; Levresse et al., 2000; Marchi et al., 2000; Narasimhan et al., 1998; Panduri et al., 2003, 2004, 2006, 2009; Shukla et al., 2003b, 2003c; Stern et al., 2006; Yuan et al., 2004).”
BackgroundMethodInfluentialReactive Oxygen Species a Double-Edged Sword for Mesothelioma
Benedetti, S., Nuvoli, B., Catalani, S., & Galati, R. (2015) · Oncotarget · doi:10.18632/oncotarget.4253 · Cited by 97
“In this context, ROS open the pore by both activating pore-destabilizing proteins (Bcl-2associated X protein, Bcl-2 homologous antagonist/ killer) and inhibiting pore-stabilizing proteins (Bcl-2 and Bcl-xL) [132].”
BackgroundInfluentialAsbestos-Induced Pulmonary Toxicity: Role of DNA Damage and Apoptosis
Upadhyay, D., & Kamp, D. W. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800602 · Cited by 83
Metadata
- Authors
- Narasimhan, S. R., Yang, L., Gerwin, B. I., & Broaddus, V. C.
- Venue
- American Journal of Physiology-Lung Cellular and Molecular Physiology
- Publisher
- American Physiological Society
- Published
- 1998-07-01
- Volume
- 275
- Issue
- 1
- Pages
- L165-L171
- ISSN
- 1040-0605 (ISSN-L)
- 1522-1504
- OpenAlex
- W166494923
- Cited by
- 91
- References
- 1
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Resistance of pleural mesothelioma cell lines to apoptosis: relation to expression of Bcl-2 and Bax. https://app.cochat.ai/papers/10.1152/ajplung.1998.275.1.l165
- The paper
- Narasimhan, S. R., Yang, L., Gerwin, B. I., & Broaddus, V. C. (1998). Resistance of pleural mesothelioma cell lines to apoptosis: relation to expression of Bcl-2 and Bax. American Journal of Physiology-Lung Cellular and Molecular Physiology. https://doi.org/10.1152/ajplung.1998.275.1.l165
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.